Purcell Dennis J

Director at AUXILIUM PHARMACEUTICALS INC · on record since Jun 15, 2007
See Footnote 1 at INTERPHARM HOLDINGS INC · on record since Nov 19, 2007
10% owner at Zeltiq Aesthetics Inc · on record since Oct 25, 2011
10% owner at INTERPHARM HOLDINGS INC · on record since Mar 3, 2008
10% owner at R&R ACQUISITION VI, INC · on record since Feb 16, 2012
10% owner at CEMPRA, INC. · on record since Feb 9, 2012
10% owner at Durata Therapeutics, Inc. · on record since Jul 25, 2012
10% owner at Esperion Therapeutics, Inc. · on record since Jun 25, 2013
10% owner at CELLULAR TECHNICAL SERVICES CO INC · on record since Sep 5, 2013
10% owner at Versartis, Inc. · on record since Mar 27, 2014
10% owner at AGILE THERAPEUTICS INC · on record since May 28, 2014
10% owner at Loxo Oncology, Inc. · on record since Jul 31, 2014
10% owner at T2 Biosystems, Inc. · on record since Aug 14, 2014
Director at AGILE THERAPEUTICS INC · on record since Jan 27, 2015
10% owner at Cidara Therapeutics, Inc. · on record since Apr 14, 2015
10% owner at ViewRay, Inc. · on record since Mar 30, 2016
Former 10% Owner at CELLULAR TECHNICAL SERVICES CO INC · on record since Feb 5, 2016
Director at VALENTIS INC · on record since Dec 7, 2004
10% owner at Syros Pharmaceuticals, Inc. · on record since Jun 29, 2016

Insider trading activity of Purcell Dennis J

Figures computed from official regulatory filings — methodology.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Company	Filed	Type	Qty	Price	Value · USD	Src
CELLULAR TECHNICAL SERVICES CO INC	Sep 5, 2013	BuyD	1,240,176.4	4.00 USD	$5M	SEC
Esperion Therapeutics, Inc.	Jul 1, 2013	OtherD	-497,666	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Jul 1, 2013	Other	1,816,475	—	—	SEC
Esperion Therapeutics, Inc.	Jul 1, 2013	OtherD	-1,816,475	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Jul 1, 2013	Buy	238,119	14.00 USD	$3.3M	SEC
Esperion Therapeutics, Inc.	Jul 1, 2013	OtherD	71,237	0.00 USD	$0	SEC
CEMPRA, INC.	Feb 9, 2012	Buy	1,213,663	6.00 USD	$7.3M	SEC
Zeltiq Aesthetics Inc	Oct 25, 2011	Buy	769,231	13.00 USD	$10M	SEC
AUXILIUM PHARMACEUTICALS INC	Jun 16, 2008	AwardD	15,000	0.00	$0	SEC
AUXILIUM PHARMACEUTICALS INC	Jun 15, 2007	AwardD	15,000	0.00	$0	SEC
AUXILIUM PHARMACEUTICALS INC	Dec 19, 2005	AwardD	-5,000	0.00 USD	—	SEC
AUXILIUM PHARMACEUTICALS INC	Aug 9, 2005	AwardD	-10,000	0.00 USD	—	SEC
VALENTIS INC	Mar 10, 2005	AwardD	10,000	—	—	SEC
VALENTIS INC	Dec 7, 2004	AwardD	10,000	—	—	SEC
AUXILIUM PHARMACEUTICALS INC	Jul 27, 2004	AwardD	10,000	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
CELLULAR TECHNICAL SERVICES CO INC	Sep 5, 2013	BuyD	1,240,176.4	4.00 USD	$5M	SEC
Esperion Therapeutics, Inc.	Jul 1, 2013	OtherD	-497,666	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Jul 1, 2013	Other	1,816,475	—	—	SEC
Esperion Therapeutics, Inc.	Jul 1, 2013	OtherD	-1,816,475	0.00 USD	$0	SEC
Esperion Therapeutics, Inc.	Jul 1, 2013	Buy	238,119	14.00 USD	$3.3M	SEC
Esperion Therapeutics, Inc.	Jul 1, 2013	OtherD	71,237	0.00 USD	$0	SEC
CEMPRA, INC.	Feb 9, 2012	Buy	1,213,663	6.00 USD	$7.3M	SEC
Zeltiq Aesthetics Inc	Oct 25, 2011	Buy	769,231	13.00 USD	$10M	SEC
AUXILIUM PHARMACEUTICALS INC	Jun 16, 2008	AwardD	15,000	0.00	$0	SEC
AUXILIUM PHARMACEUTICALS INC	Jun 15, 2007	AwardD	15,000	0.00	$0	SEC
AUXILIUM PHARMACEUTICALS INC	Dec 19, 2005	AwardD	-5,000	0.00 USD	—	SEC
AUXILIUM PHARMACEUTICALS INC	Aug 9, 2005	AwardD	-10,000	0.00 USD	—	SEC
VALENTIS INC	Mar 10, 2005	AwardD	10,000	—	—	SEC
VALENTIS INC	Dec 7, 2004	AwardD	10,000	—	—	SEC
AUXILIUM PHARMACEUTICALS INC	Jul 27, 2004	AwardD	10,000	0.00 USD	—	SEC